Appili Therapeutics Inc Capital Reinvestment Ratio
Appili Therapeutics Inc capital reinvestment ratio. Appili Therapeutics Inc (APLI) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow (CA$1.03 Million) in capital expenditures (CA$2.36K). See Appili Therapeutics Inc (APLI) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Appili Therapeutics Inc (2025–2025)
Capital reinvestment ratio of Appili Therapeutics Inc from 2025 to 2025. This chart tracks Appili Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. See APLI financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Appili Therapeutics Inc Capital Reinvestment Ratio by Year (2025–2025)
Appili Therapeutics Inc capital reinvestment ratio by year from 2025 to 2025. For the full cash flow conversion analysis, see Appili Therapeutics Inc (APLI) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | CA$868.82K | CA$2.36K | — |